ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
LSL Pharma Group Inc

LSL Pharma Group Inc (LSL)

0.38
0.00
( 0.00% )
Updated: 02:48:16

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.38
Bid
0.375
Offer
0.38
Volume
25,100
0.375 Day's Range 0.38
0.31 52 Week Range 0.55
Market Cap
Previous Close
0.38
Open
0.38
Last Trade
11000
@
0.38
Last Trade Time
02:47:58
Financial Volume
-
VWAP
-
Average Volume (3m)
42,773
Shares Outstanding
82,435,000
Dividend Yield
-
PE Ratio
-3.70
Earnings Per Share (EPS)
-0.1
Revenue
10.03M
Net Profit
-8.47M

About LSL Pharma Group Inc

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Headquarters
Quebec City, Quebec, Can
Founded
2011
LSL Pharma Group Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker LSL. The last closing price for LSL Pharma was $0.38. Over the last year, LSL Pharma shares have traded in a share price range of $ 0.31 to $ 0.55.

LSL Pharma currently has 82,435,000 shares in issue. The market capitalisation of LSL Pharma is $31.33 million. LSL Pharma has a price to earnings ratio (PE ratio) of -3.70.

LSL Latest News

LSL PHARMA GROUP EXPANDS ITS ACTIVITIES BY AQUIRING DERMOLAB PHARMA AND ANNOUNCES THE CLOSING OF A CONCURRENT DEBT FINANCING

LSL PHARMA GROUP EXPANDS ITS ACTIVITIES BY AQUIRING DERMOLAB PHARMA AND ANNOUNCES THE CLOSING OF A CONCURRENT DEBT FINANCING Canada NewsWire BOUCHERVILLE, QC, Dec. 18, 2024 Acquisition is...

LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES

LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES Canada NewsWire BOUCHERVILLE, QC, Nov. 25, 2024 Revenues of $4.0 million...

LSL PHARMA GROUP ANNONCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP

LSL PHARMA GROUP ANNONCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP Canada NewsWire BOUCHERVILLE, QC, Nov. 6, 2024...

LSL PHARMA GROUP ANNOUNCES THE FIRST INTEREST PAYMENT ON THE CONVERTIBLE DEBENTURES LISTED AS LSL.DB

LSL PHARMA GROUP ANNOUNCES THE FIRST INTEREST PAYMENT ON THE CONVERTIBLE DEBENTURES LISTED AS LSL.DB Canada NewsWire BOUCHERVILLE, QC, Oct. 24, 2024 BOUCHERVILLE, QC, Oct. 24, 2024 /CNW/ - LSL...

LSL PHARMA GROUP ANNOUNCES CHANGE OF AUDITORS AND GRANT OF OPTIONS

LSL PHARMA GROUP ANNOUNCES CHANGE OF AUDITORS AND GRANT OF OPTIONS Canada NewsWire BOUCHERVILLE, QC, Sept. 26, 2024 BOUCHERVILLE, QC, Sept. 26, 2024 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL...

LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024

LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024 Canada NewsWire BOUCHERVILLE, QC, Aug. 26, 2024 Record Revenues of $4.2 million in Q2-24 up 106% over Q2-23Operating profits...

LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt

BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to...

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased...

LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement

BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced...

LSL Pharma Group Completes the Acquisition of Virage Santé

BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.035-8.433734939760.4150.4150.375185560.39268916CS
40.03510.14492753620.3450.420.31397360.37989082CS
12-0.02-50.40.490.31427730.40962593CS
26-0.12-240.50.50.31340950.43148151CS
52-0.12-240.50.550.31315860.43329888CS
156-0.32-45.71428571430.710.31263930.45782972CS
260-0.32-45.71428571430.710.31263930.45782972CS

LSL - Frequently Asked Questions (FAQ)

What is the current LSL Pharma share price?
The current share price of LSL Pharma is $ 0.38
How many LSL Pharma shares are in issue?
LSL Pharma has 82,435,000 shares in issue
What is the market cap of LSL Pharma?
The market capitalisation of LSL Pharma is CAD 31.33M
What is the 1 year trading range for LSL Pharma share price?
LSL Pharma has traded in the range of $ 0.31 to $ 0.55 during the past year
What is the PE ratio of LSL Pharma?
The price to earnings ratio of LSL Pharma is -3.7
What is the cash to sales ratio of LSL Pharma?
The cash to sales ratio of LSL Pharma is 3.13
What is the reporting currency for LSL Pharma?
LSL Pharma reports financial results in CAD
What is the latest annual turnover for LSL Pharma?
The latest annual turnover of LSL Pharma is CAD 10.03M
What is the latest annual profit for LSL Pharma?
The latest annual profit of LSL Pharma is CAD -8.47M
What is the registered address of LSL Pharma?
The registered address for LSL Pharma is 540, RUE D’AVAUGOUR, BOUCHERVILLE, QUEBEC CITY, QUEBEC, J4B 0G6
What is the LSL Pharma website address?
The website address for LSL Pharma is www.groupelslpharma.com
Which industry sector does LSL Pharma operate in?
LSL Pharma operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTGCentenario Gold Corp
$ 0.02
(100.00%)
650.1k
TKUTarku Resources Ltd
$ 0.015
(50.00%)
94k
TOHTotal Helium Ltd
$ 0.015
(50.00%)
3k
KSKlondike Silver Corp
$ 0.015
(50.00%)
118.33k
ENRGNew Energy Metals Corp
$ 0.325
(47.73%)
500
TVITVI Pacific Inc
$ 0.005
(-50.00%)
20k
MNLXMiniluxe Holding Corp
$ 0.465
(-38.00%)
4.4k
MTLOMartello Technologies Group Inc
$ 0.01
(-33.33%)
22k
PGDCPatagonia Gold Corp
$ 0.035
(-30.00%)
36.3k
QGRQ Gold Resources Ltd
$ 0.08
(-27.27%)
55.85k
XBOTRealbotix Corp
$ 0.68
(11.48%)
6.13M
QNCQuantum Emotion Corp
$ 0.72
(-20.00%)
3.54M
WWTWater Ways Technologies Inc
$ 0.005
(0.00%)
2.1M
GPUSAlset AI Ventures Inc
$ 0.17
(-8.11%)
1.46M
THRMTherma Bright Inc
$ 0.045
(12.50%)
1.36M

Discussion

View Full Feed
Truth and Transparency Truth and Transparency 4 minutes ago
Buy more shares now to bring your overall share price down. Great buying opportunity at these decade lows. Don’t look a gift horse in the mouth. Be thankful, not critical…..lol

Of course, im being very sarcastic. Mark Smith and his dream team have failed the investors who have support
NB
DewDiligence DewDiligence 4 minutes ago
Thanks. I may have stretched by pigeonholing the GSK deal as immunology, but it does bring the potential for GSK to expand into KIT immunology, as you noted.
ENTA
The Penny Preacher The Penny Preacher 4 minutes ago
SNL has nothing on the Hub.

Best entertainment forum on the web.

TPP
trunkmonk trunkmonk 4 minutes ago
Those meds do wonders.
FNMA
Hi_Lo Hi_Lo 4 minutes ago
Like I said last week - this small BS run is over. There was no reason for it to begin with.

This will be back to .001 - .002 in no time.

GVSI is a regulatory disaster and a scam.
GVSI
ace65 ace65 5 minutes ago
WE READY ?...7 mil.buy at .0003 just hit..need more chunky buys.
TKMO
BluE33 BluE33 5 minutes ago
That Fontalk website looks very impressive!
ASII
BRoberts1982 BRoberts1982 5 minutes ago
The day by day of non news will be a slow drop in CLNV price.
The CLNV price drop will speed up as the end of the month gets closer
CLNV will be hitting .015 range next.

If we start February and there is NO NEWS then CLNV should expect
CLNV price back to LOW teen
CLNV
firebag1 firebag1 5 minutes ago
nice news
LITM
Rambo Rell Rambo Rell 5 minutes ago
$ILLR: AI-Driven Innovation
With cutting-edge AI integrations, Triller is providing creators unparalleled tools to amplify their reach and engagement. Invest in technology. Invest in Triller. #AIFuture #ILLR
ILLR
dexprs dexprs 5 minutes ago
Sold NVDA 10 Puts, would have liked to sell 15, but I do not like the trend for the short term.
NVDA
Rambo Rell Rambo Rell 5 minutes ago
$ILLR: AI-Driven Innovation
With cutting-edge AI integrations, Triller is providing creators unparalleled tools to amplify their reach and engagement. Invest in technology. Invest in Triller. #AIFuture #ILLR
ILLR
Rambo Rell Rambo Rell 5 minutes ago
$ILLR: Monetization at Its Core
Our focus on enhancing monetization tools gives creators a platform to turn their passion into profit. Triller is the backbone of creator success. #InvestSmart #ILLR
ILLR
Rambo Rell Rambo Rell 5 minutes ago
$ILLR: Monetization at Its Core
Our focus on enhancing monetization tools gives creators a platform to turn their passion into profit. Triller is the backbone of creator success. #InvestSmart #ILLR
ILLR
axelvento axelvento 6 minutes ago
Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited)

Updates 2025 expected revenue range to $1.5 to 2.5 billion

Expects to reduce 2025 cash cost expenses by $1.0 billion with a plan for addit
MRNA
halbroke1 halbroke1 6 minutes ago
UMAV $$$ SO CRAZY UNDERVALUED HERE.....SHOULD BE HEADING TO MULTI-DOLLARS....WAIT TILL TRUMP GETS IN THE MARKETS WILL GO CRAZY, TO THE MOON..
UMAV
fung_derf fung_derf 7 minutes ago
Great post! There are some good stocks you've mentioned and some worth looking further into.
FWIW, I've probably never listed every stock I own. Many that you list I've either owned in the past or still do. I am quite diverse. Of the ones you listed, I currently own (and in the same industry)
TPL UFPI UGI
Stino2 Stino2 7 minutes ago
is there someone home here?
PHUN
getmoreshares getmoreshares 7 minutes ago
33m ask at 5
CGAC
Number sleven Number sleven 7 minutes ago
Kiwi, I own eypt. Phase 2 trial ends this month. Should be positive. The phase 3 that ocular is running should also be positive. Based on the phase 1 results. Considering a trade.
Sleven,
OCUL
eagle8 eagle8 7 minutes ago
Yes indeed and with a revenue of $4 billion in the near future (within 1 to 2 years) an MC of almost $100 billion.
And in anticipation of this turnover an MC of $35 billion after approval is not so crazy.
Not bad either, right?
Just keep shorting, then at least you know what to
NWBO
DDA DDA 7 minutes ago
Knowing this is a low floater ... estimated 50-70 million max. ... someone is collecting.


1 Jan 2025
0.00975
0.00375
62.50%
0.0081
0.00975
0.0041
654,861

1 Jan 2024
0.006
0.00245
69.01%
STGZ
Renee Renee 7 minutes ago
LFAP SEC registration revoked:

https://www.sec.gov/files/litigation/opinions/2025/34-102149.pdf
LFAP
JusDePomme JusDePomme 7 minutes ago
Someone sold to me .0004 more...goodness volume
AFFU